Chapter title |
Machine Learning from Omics Data.
|
---|---|
Chapter number | 18 |
Book title |
Artificial Intelligence in Drug Design
|
Published in |
Methods in molecular biology, January 2022
|
DOI | 10.1007/978-1-0716-1787-8_18 |
Pubmed ID | |
Book ISBNs |
978-1-07-161786-1, 978-1-07-161787-8
|
Authors |
Rex, René |
Abstract |
Machine learning (ML) already accelerates discoveries in many scientific fields and is the driver behind several new products. Recently, growing sample sizes enabled the use of ML approaches in larger omics studies. This work provides a guide through a typical analysis of an omics dataset using ML. As an example, this chapter demonstrates how to build a model predicting Drug-Induced Liver Injury based on transcriptomics data contained in the LINCS L1000 dataset. Each section covers best practices and pitfalls starting from data exploration and model training including hyperparameter search to validation and analysis of the final model. The code to reproduce the results is available at https://github.com/Evotec-Bioinformatics/ml-from-omics . |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 13 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 3 | 23% |
Student > Ph. D. Student | 2 | 15% |
Other | 1 | 8% |
Student > Bachelor | 1 | 8% |
Professor | 1 | 8% |
Other | 2 | 15% |
Unknown | 3 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Computer Science | 3 | 23% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 15% |
Biochemistry, Genetics and Molecular Biology | 1 | 8% |
Agricultural and Biological Sciences | 1 | 8% |
Immunology and Microbiology | 1 | 8% |
Other | 2 | 15% |
Unknown | 3 | 23% |